Seguridad de los excipientes en medicamentos pediátricos: impacto en la salud infantil

A Pharmacovigilance Analysis of Ocular Adverse Events Associated with GLP-1 Receptor Agonists

International Medicinal Product Information Documents: A Quantitative Content Analysis of Instructions for Preventing, Mitigating, and Monitoring Adverse Drug Reactions

Toxicity of nanostructures in drug delivery applications

Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)

Pharmacovigilance Evaluation of Amoxicillin Induced Adverse Drug Reactions

Strengthening Pharmacovigilance in Latin America: Multidisciplinary Insights from Two ISoP Latin American Chapter Symposia

Assessment of Challenges in Combating Counterfeit, Substandard, and Adulterated Medicines in Private Pharmacy Business Management

Evaluating Treatment and Safety Outcomes of a Shorter Regimen for Drug-Resistant TB in Nigeria: An Implementation Research Study

Machine learning-based prediction of drug lactation risk: Bridging molecular features and breastfeeding safety

Profiles of neuropsychiatric toxicity associated with different endocrine therapies for breast cancer: a global pharmacovigilance study based on FAERS and VigiAccess

Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)

Substances of human origin (SoHO): review of UK legislation - call for evidence document

MHRA approach to medicines using non-animal methods

FDA black box warnings: characteristics of drug classes and adverse effects

Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines

Artificial Intelligence for Adverse Drug Event Prediction: Integrative Multi-Modal Modeling, Clinical Translation, and Regulatory Alignment in Pharmacovigilance

Un joven de Zamora crea una app con IA que puede evitar errores con medicamentos

MHRA action boosts drive to phase out animal testing

Research progress on the intrinsic link between the occurrence and progression of malignant tumors, chronic kidney disease and drug safety

No hay una alerta sanitaria en España por medicamentos con fenilpropalamina: es un bulo de WhatsApp

Pharmacovigilance capacity and readiness of vaccine manufacturers in low- and middle-income countries: a maturity-based assessment of the pharmacovigilance system

Pharmacovigilance and Adverse Drug Reaction Reporting: Regulatory Framework, Challenges, and Future Perspectives.

Machine learning studies of drug-induced nephrotoxicity: a scoping review

Risk factors for drug-related ischemic stroke: an analysis of the FDA adverse event reporting system (FAERS)

Real-world pharmacovigilance of tobramycin/dexamethasone: A safety signal analysis using the the Food and Drug Administration Adverse Event Reporting System (FAERS)

La AEMPS publica el Informe Anual del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano

Hidden antibiotics in river fish spark new food safety fears

Alerta por presencia de sildenafilo en complemento alimenticio. (Ref. ES2026/148)

¿Es la grasa visceral un marcador de toxicidad por metotrexato en población pediátrica con leucemia?

Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria

Prevalence of severe fatigue after SARS-CoV-2 infection in Norway: a prospective 2-year follow-up study

Hydralazine Use and Risk of Vasculitis

Incidence of Adverse Events in Peripheral Intravenous Vasopressor Use. A Systematic Review and Meta-Analysis

Molecular mechanisms and clinical patterns of ICI-associated acute kidney failure: an integrated pharmacovigilance and pathway analysis

The Mark of Confusion: Untangling the Circuit Split in Trademark Infringement Jurisprudence

Incidence and trends of adverse drug reactions during seasonal malaria chemoprevention among children: evidence from Ghana's pharmacovigilance database, 2015-2023

A dataset of medication images with instance segmentation masks for preventing adverse drug events

Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management

Charting and Sidestepping the Pitfalls of Disproportionality Analysis